iShares Biotechnology ETF IBB

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IBB

Will IBB outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Biotechnology ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBB

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 50.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

8.40 906M
Healthcare

Amgen Inc

7.94 855M
Healthcare

Vertex Pharmaceuticals Inc

7.61 820M
Healthcare

Moderna Inc

5.65 609M
Healthcare

Regeneron Pharmaceuticals Inc

5.47 589M
Healthcare

Natera Inc

3.87 417M
Healthcare

argenx SE ADR

3.26 352M
Healthcare

Illumina Inc

3.01 325M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.70 291M
Healthcare

Biogen Inc

2.43 262M
Healthcare

Sponsor Center